PPARγ inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PPARγ inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells

Published:2019-03-25 Issue:5 Volume:23 Page:3724-3736
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Cheng Songtao¹^ORCID,Qian Kaiyu²³⁴,Wang Yejinpeng¹,Wang Gang²³⁴,Liu Xuefeng⁵,Xiao Yu¹²³⁴^ORCID,Wang Xinghuan¹⁶

Affiliation:

1. Department of Urology Zhongnan Hospital of Wuhan University Wuhan China

2. Department of Biological Repositories Zhongnan Hospital of Wuhan University Wuhan China

3. Human Genetics Resource Preservation Center of Hubei Province Wuhan China

4. Laboratory of Precision Medicine Zhongnan Hospital of Wuhan University Wuhan China

5. Department of Pathology Lombardi Comprehensive Cancer Center, Georgetown University Medical School Washington District of Columbia

6. Medical Research Institute, Wuhan University Wuhan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.14280

Reference60 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines

3. Urothelial carcinoma of the bladder: definition, treatment and future efforts

4. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

5. Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer;Nature Communications;2024-08-02

2. Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways;Frontiers in Cell and Developmental Biology;2024-06-12

3. Dual function of activated PPARγ by ligands on tumor growth and immunotherapy;Medical Oncology;2024-04-15

4. Cancer biology in diabetes update: Focusing on antidiabetic drugs;Journal of Diabetes Investigation;2024-03-08

5. Adipocyte‑rich microenvironment promotes chemoresistance via upregulation of peroxisome proliferator‑activated receptor gamma/ABCG2 in epithelial ovarian cancer;International Journal of Molecular Medicine;2024-02-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3